caffeine and doxapram
caffeine has been researched along with doxapram in 30 studies
Research
Studies (30)
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 10 (33.33) | 18.7374 |
| 1990's | 5 (16.67) | 18.2507 |
| 2000's | 7 (23.33) | 29.6817 |
| 2010's | 4 (13.33) | 24.3611 |
| 2020's | 4 (13.33) | 2.80 |
Authors
| Authors | Studies |
|---|---|
| Lombardo, F; Obach, RS; Waters, NJ | 1 |
| Chang, G; El-Kattan, A; Miller, HR; Obach, RS; Rotter, C; Steyn, SJ; Troutman, MD; Varma, MV | 1 |
| Glen, RC; Lowe, R; Mitchell, JB | 1 |
| Chen, M; Hu, C; Suzuki, A; Thakkar, S; Tong, W; Yu, K | 1 |
| Cohn, M; Cohn, ML; Kraynack, BJ; Taylor, FH | 1 |
| Bonora, M; Gautier, H; Milic-Emili, J; Siafakas, NM | 1 |
| Day, MA; Neims, AH; Piercy, WN; Williams, RL | 1 |
| Aranda, JV; Bairam, A; Blanchard, PW; Bureau, MA; Cote, A; Laudignon, N | 1 |
| Irani, AJ; Merchant, RH | 1 |
| Boyet, S; Nehlig, A; Schroeder, H | 1 |
| Jauchem, JR | 1 |
| Bairam, A; Vert, P | 1 |
| Winnie, AP | 1 |
| DaVanzo, JP; Kang, LS; Kline, ES; Ward, JW; Watterson, JR | 1 |
| Bonora, M; Gautier, H | 1 |
| Chernick, V; Ioffe, S; Jansen, AH | 1 |
| Huon, C; Moriette, G; Mussat, P; Parat, S; Relier, JP | 1 |
| Huon, C; Moriette, G; Mussat, P; Parat, S; Rey, E | 1 |
| Bohnhorst, B; Darraj, S; Poets, CF | 1 |
| Bhatia, J | 1 |
| Barbé, F; Boutroy, MJ; Fresson, J; Hascoët, JM; Maillard, C | 1 |
| Bhatt-Mehta, V; Schumacher, RE | 1 |
| Bury, G; Charles, B; Charlton, M; Flenady, V; Fraser, S; Gray, PH; Hegarty, J; Henderson-Smart, D; Horton, L; Jacklin, R; Reid, S; Rogers, Y; Shearman, A; Steer, P; Walsh, A | 1 |
| Gaugler, C; Marlier, L; Messer, J | 1 |
| Giguère, S; Robertson, SA; Sanchez, LC; Shih, A; Szabo, NJ; Womble, AY | 1 |
| Onland, W; Ten Hove, CH; van Kaam, AH; Vliegenthart, RJ | 1 |
| Engbers, AGJ; Flint, RB; Knibbe, CAJ; Koch, BCP; Poets, CF; Reiss, IKM; Simons, SHP; Völler, S | 1 |
| Koch, G; van den Anker, JN | 1 |
| Allegaert, K; Carkeek, K; Cassart, V; Cornette, L; de Boode, WP; de Kort, EHM; Dijk, PH; Flint, RB; Hemels, MAC; Hermans, I; Hutten, GJ; Hütten, MC; Kelen, D; Kroon, AA; Lacaze-Masmonteil, T; Lefevere, J; Nuytemans, DH; Onland, W; Pas, ABT; Plaskie, K; Poley, MJ; Poppe, JA; Reiss, IKM; Simons, SHP; Smits, A; Stewart, B; Storm, KK; van Kaam, AH; van Weissenbruch, MM; Voeten, M; Willemsen, SP; Williams, O; Zonnenberg, IA | 1 |
| Avdic, E; Bruschettini, M; Evans, S; Fiander, M; Pessano, S; Soll, R | 1 |
Reviews
7 review(s) available for caffeine and doxapram
| Article | Year |
|---|---|
DILIrank: the largest reference drug list ranked by the risk for developing drug-induced liver injury in humans.
Topics: Chemical and Drug Induced Liver Injury; Databases, Factual; Drug Labeling; Humans; Pharmaceutical Preparations; Risk | 2016 |
Pharmacotherapy of neonatal apnea.
Topics: Apnea; Caffeine; Citrates; Doxapram; Drug Combinations; Humans; Infant, Newborn; Theophylline | 1991 |
Effects of drugs on thermal responses to microwaves.
Topics: Adrenergic beta-Antagonists; Analgesics; Anesthetics; Animals; Bemegride; Body Temperature; Caffeine; Cardiac Glycosides; Chlorpromazine; Cholinesterase Inhibitors; Doxapram; Glucocorticoids; Hexamethonium; Hexamethonium Compounds; Microwaves; Nicotine; Nikethamide; Parasympatholytics; Parasympathomimetics; Pentylenetetrazole; Serotonin; Sympathomimetics; Vitamins | 1985 |
Current options in the management of apnea of prematurity.
Topics: Apnea; Caffeine; Central Nervous System Stimulants; Doxapram; Humans; Infant, Newborn; Infant, Premature; Infant, Premature, Diseases; Theophylline; Xanthines | 2000 |
Treatment of apnea of prematurity.
Topics: Aminophylline; Apnea; Caffeine; Clinical Trials as Topic; Doxapram; Humans; Infant, Newborn; Infant, Premature; Respiratory System Agents; Theophylline | 2003 |
Doxapram Treatment for Apnea of Prematurity: A Systematic Review.
Topics: Apnea; Caffeine; Doxapram; Gestational Age; Humans; Infant; Infant, Newborn; Infant, Premature; Infant, Premature, Diseases; Randomized Controlled Trials as Topic; Respiratory System Agents; Theophylline | 2017 |
Doxapram for the prevention and treatment of apnea in preterm infants.
Topics: Aminophylline; Apnea; Caffeine; Doxapram; Humans; Infant, Newborn; Infant, Premature; Lung Diseases | 2023 |
Trials
9 trial(s) available for caffeine and doxapram
| Article | Year |
|---|---|
Chemical respirogenesis: a comparative study.
Topics: Adult; Aminobutyrates; Aminophylline; Bemegride; Benzamides; Blood Pressure; Caffeine; Central Nervous System Stimulants; Doxapram; Female; Humans; Lobeline; Methylphenidate; Nikethamide; Pentylenetetrazole; Placebos; Pulse; Quinolizines; Respiration; Respiratory Tract Diseases; Spirometry | 1973 |
Use of preestablished criteria for deciding on extubation in the very low birthweight newborn. Preliminary analysis of a randomized study.
Topics: Caffeine; Double-Blind Method; Doxapram; Humans; Infant; Infant, Low Birth Weight; Infant, Newborn; Oxygen Inhalation Therapy; Prospective Studies; Respiration, Artificial; Retrospective Studies; Time Factors | 1993 |
Low-dose doxapram for treatment of apnoea following early weaning in very low birthweight infants: a randomized, double-blind study.
Topics: Apnea; Blood Pressure; Caffeine; Central Nervous System Stimulants; Double-Blind Method; Doxapram; Humans; Infant, Newborn; Infant, Very Low Birth Weight; Infusions, Intravenous; Respiratory System Agents; Treatment Outcome; Ventilator Weaning | 1998 |
Effect of doxapram on episodes of apnoea, bradycardia and hypoxaemia in preterm infants.
Topics: Apnea; Birth Weight; Bradycardia; Caffeine; Doxapram; Drug Resistance; Gestational Age; Humans; Hypoxia; Infant, Newborn; Infant, Premature; Infant, Premature, Diseases; Infusions, Intravenous; Intubation, Gastrointestinal; Oxygen; Respiratory System Agents | 1999 |
QT interval lengthening in premature infants treated with doxapram.
Topics: Caffeine; Central Nervous System Stimulants; Doxapram; Drug Interactions; Female; Gestational Age; Hemodynamics; Humans; Infant, Newborn; Infant, Premature; Long QT Syndrome; Male | 2001 |
High dose caffeine citrate for extubation of preterm infants: a randomised controlled trial.
Topics: Caffeine; Citrates; Double-Blind Method; Doxapram; Drug Combinations; Female; Gestational Age; Humans; Infant, Newborn; Infant, Premature; Male; Respiration, Artificial; Respiratory System Agents; Time Factors; Treatment Outcome; Ventilator Weaning | 2004 |
Olfactory stimulation prevents apnea in premature newborns.
Topics: Apnea; Aromatherapy; Bradycardia; Caffeine; Central Nervous System Stimulants; Combined Modality Therapy; Doxapram; Drug Therapy, Combination; Humans; Infant, Newborn; Infant, Premature; Infant, Premature, Diseases; Odorants; Physical Stimulation; Respiratory System Agents; Smell | 2005 |
Comparison of the effects of caffeine and doxapram on respiratory and cardiovascular function in foals with induced respiratory acidosis.
Topics: Acidosis, Respiratory; Anesthetics, Inhalation; Animals; Caffeine; Central Nervous System Stimulants; Dose-Response Relationship, Drug; Doxapram; Horses; Isoflurane | 2007 |
Doxapram versus placebo in preterm newborns: a study protocol for an international double blinded multicentre randomized controlled trial (DOXA-trial).
Topics: Bronchopulmonary Dysplasia; Caffeine; Double-Blind Method; Doxapram; Gestational Age; Humans; Infant; Infant, Newborn; Infant, Premature; Multicenter Studies as Topic; Randomized Controlled Trials as Topic | 2023 |
Other Studies
14 other study(ies) available for caffeine and doxapram
| Article | Year |
|---|---|
Trend analysis of a database of intravenous pharmacokinetic parameters in humans for 670 drug compounds.
Topics: Blood Proteins; Half-Life; Humans; Hydrogen Bonding; Infusions, Intravenous; Pharmacokinetics; Protein Binding | 2008 |
Physicochemical space for optimum oral bioavailability: contribution of human intestinal absorption and first-pass elimination.
Topics: Administration, Oral; Biological Availability; Humans; Intestinal Absorption; Pharmaceutical Preparations | 2010 |
Predicting phospholipidosis using machine learning.
Topics: Animals; Artificial Intelligence; Databases, Factual; Drug Discovery; Humans; Lipidoses; Models, Biological; Phospholipids; Support Vector Machine | 2010 |
Comparisons between the antianesthetic action of dibutyryl cyclic AMP and analeptic drugs on amobarbital-induced narcosis in the rat.
Topics: Amobarbital; Amphetamines; Anesthetics; Animals; Benzamides; Bucladesine; Caffeine; Central Nervous System Stimulants; Doxapram; Male; Pentylenetetrazole; Picrotoxin; Rats; Strychnine; Theophylline | 1976 |
[Ventilatory effects of various respiratory stimulants in awake cats (author's transl)].
Topics: Almitrine; Animals; Caffeine; Carbon Dioxide; Cats; Central Nervous System; Central Nervous System Stimulants; Consciousness; Doxapram; Drug Interactions; Hypercapnia; Oxygen; Peripheral Nerves; Piperazines; Respiration; Respiratory Function Tests; Triazines | 1979 |
Alteration of ovine fetal respiratory-like activity by diazepam, caffeine, and doxapram.
Topics: Animals; Blood Gas Analysis; Caffeine; Depression, Chemical; Diazepam; Doxapram; Female; Fetal Blood; Fetus; Infusions, Parenteral; Pregnancy; Pressure; Respiration; Sheep; Stimulation, Chemical; Trachea | 1977 |
Interactive ventilatory effects of two respiratory stimulants, caffeine and doxapram, in newborn lambs.
Topics: Animals; Animals, Newborn; Behavior, Animal; Blood Pressure; Caffeine; Dose-Response Relationship, Drug; Doxapram; Drug Synergism; Infusions, Intravenous; Pulmonary Ventilation; Respiration; Sheep; Tidal Volume | 1992 |
Effects of caffeine and doxapram perfusion on local cerebral glucose utilization in conscious rats.
Topics: Animals; Autoradiography; Blood Gas Analysis; Blood Pressure; Body Temperature; Brain; Caffeine; Deoxyglucose; Doxapram; Energy Metabolism; Glucose; In Vitro Techniques; Male; Perfusion; Rats; Rats, Inbred Strains | 1989 |
Low-dose doxapram for apnoea of prematurity.
Topics: Apnea; Caffeine; Doxapram; Drug Therapy, Combination; Humans; Infant, Newborn; Infant, Premature, Diseases; Pilot Projects; Recurrence | 1986 |
Species dependent effects of doxapram HCl on alcohol dehydrogenase activity.
Topics: Alcohol Oxidoreductases; Alcohols; Animals; Bemegride; Benzamides; Caffeine; Central Nervous System Stimulants; Dextroamphetamine; Dogs; Doxapram; Electrophoresis; Ethanol; Female; Glycols; Guinea Pigs; Horses; In Vitro Techniques; L-Lactate Dehydrogenase; Liver; Methylphenidate; Mice; Microsomes; Morpholines; Nikethamide; Pentylenetetrazole; Propylene Glycols; Pyrrolidinones; Rabbits; Rats; Species Specificity | 1969 |
Possible alterations in brain monoamine metabolism during hypoxia-induced tachypnea in cats.
Topics: Aminophylline; Animals; Biogenic Amines; Brain; Caffeine; Carbidopa; Cats; Dihydroxyphenylalanine; Doxapram; Hypercapnia; Hypoxia; Respiration Disorders | 1980 |
Drug-induced changes in fetal breathing activity and sleep state.
Topics: Animals; Caffeine; Doxapram; Female; Fetus; Indomethacin; Pilocarpine; Pregnancy; Respiration; Sheep; Sleep; Sodium Cyanide | 1983 |
The Pharmacokinetics of Caffeine in Preterm Newborns: No Influence of Doxapram but Important Maturation with Age.
Topics: Apnea; Caffeine; Doxapram; Humans; Infant; Infant, Newborn; Infant, Premature; Infant, Premature, Diseases | 2021 |
Not Only Preterm Neonates Mature but Also Traditional Dosing Regimens Have to Mature: The Role of Mathematical Modeling.
Topics: Caffeine; Clinical Protocols; Doxapram; Gestational Age; Humans; Infant, Newborn; Infant, Premature | 2021 |